RSA Insurance Group (LON:RSA)‘s stock had its “under review” rating restated by equities researchers at Shore Capital in a research report issued on Friday, September 28th.
Several other analysts have also recently commented on RSA. JPMorgan Chase & Co. raised their target price on shares of RSA Insurance Group from GBX 725 ($9.47) to GBX 735 ($9.60) and gave the stock an “overweight” rating in a research note on Friday, July 13th. Barclays reduced their price objective on shares of RSA Insurance Group from GBX 684 ($8.94) to GBX 682 ($8.91) and set an “overweight” rating for the company in a research note on Wednesday, July 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and nine have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of GBX 668.58 ($8.74).
Shares of LON:RSA opened at GBX 569.80 ($7.45) on Friday. RSA Insurance Group has a 52-week low of GBX 568.50 ($7.43) and a 52-week high of GBX 672.50 ($8.79).
RSA Insurance Group Company Profile
RSA Insurance Group plc, together with its subsidiaries, provides personal and commercial general insurance products. It operates through Scandinavia, Canada, and UK & International segments. The company offers a range of personal insurance products, including home, car, pet, and travel insurance products directly to its customers, as well as through brokers and agents.
Recommended Story: Marijuana Stocks
Receive News & Ratings for RSA Insurance Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RSA Insurance Group and related companies with MarketBeat.com's FREE daily email newsletter.